Maria Felton Lowry

PharmD, BCPS, BCGP
Assistant Professor

Office location: Iroquois Building, Suite 308.15

Bio:
Dr. Lowry’s passion lies with improving the quality of life for seriously ill patients through the practice and teaching of rational medication use.

Dr. Lowry received her PharmD from the University of Pittsburgh School of Pharmacy. She then completed a Post-Graduate Year One Pharmacy Practice and Post-Graduate Year Two Geriatric Residency at UPMC St. Margaret as well as an Interprofessional Faculty Development Fellowship through University of Pittsburgh Department of Family Medicine in Pittsburgh, PA. Dr. Lowry is a Board Certified Pharmacotherapy Specialist and a Board Certified Geriatric Pharmacist. After completion of her training, she served as a Palliative Care Clinical Pharmacy Specialist at MedStar Health for 3.5 years where she was awarded the Dr. Thomas Wilson Clinician of the Year Award in 2019 before joining the Pitt Pharmacy faculty.

Dr. Lowry’s clinical practice site is the University of Pittsburgh Medical Center (UPMC) Palliative Supportive Institute (PSI) as the Palliative Care Clinical Pharmacy Specialist.

Practice Area/Expertise
Pain/Palliative Care
Honors / Awards
2023 Society of Pain and Palliative Care Pharmacists, Palliative Care Representative, Board of Trustees
2019 Dr. Thomas Wilson Clinician of the Year Award, MedStar Health Palliative Care
Recent Publications

Felton MA, van Londen J, Marcum ZA. Medication Adherence to Oral Cancer Therapy: The Promising Role of the Pharmacist. J Onc Pharm Pract 2014 Aug. PMID: 25380658
Kane-Gill SL, Smithburger PA, Williams E, Felton MA, Wang N, Seybert AL. Published cases of adverse drug reactions: Has the quality of reporting improved over times? Ann Pharmacother 2014 Sept. PMID: 25922652
Felton MA Marcum Z, Perera S, and Hanlon JT. Racial differences in anticholinergic use among community dwelling elders. Consult Pharm 2014 Sept. PMID: 25893702
Felton MA, Weinberg R, Pruskowski J. Olanzapine for nausea, delirium, anxiety, insomnia, and cachexia #315. J Palliat Med. 2016 Nov;19(11):1224-1225. PMID: 27267313
Felton MA, Jarrett JB, Meyer S. Geriatric Care Curriculum in US PharmD Programs: What’s Happening? Currents in Pharmacy Teaching and Learning. 2017 May-Jun. 9(3):504-509. PMID: 29233292
Ie K, Felton M, Springer S, Wilson SA, Albert SM. Physician factors associated with polypharmacy and potentially inappropriate medication use. JABFM. July-August 2017: 30(4):528-536. PMID: 28720634
Ie K, Felton M, Springer S, Wilson SA, Albert SM. Multimorbidity and polypharmacy in family medicine residency practices. Journal of Pharmacy Technology. 2017 Dec;33(6):219-224. PMID:PMC5998471
Felton MA, Jarrett JB, Hoffmaster R, D’Amico F, Sakely S, Pruskowski J. Comparison of haloperidol, non-haloperidol antipsychotics, and no pharmacotherapy for the management of delirium in an inpatient geriatric palliative care population. Journal of Pain & Palliative Care Pharmacotherapy. Jun-Sept 2018. 32(2-3):141-148. PMID: 31066639
Felton MA, Tannenbaum C, McPherson L, Pruskowski J. Communication techniques for initiating a deprescribing conversation #369. J Palliat Med. 2019 Feb;22(3):335-336. PMID: 30794498.
DeAngelis J, Lowry MF. Hospital readmissions in hospice patients: Evaluation of medication-related causes for readmission. American Journal of Hospice & Palliative Medicine. 2021 Jul;38(7):745-749. PMID: 32935551
Reisfield G, Lowry MF, Wilson GR. Cancer-related fatigue #173. J Palliat Med. 2021 Nov. Online update: https://www.mypcnow.org/fast-fact/cancer-related-fatigue/?msclkid=0942f…
Lockman K, Lowry MF, DiScala S, Lovell AG, Uritsky TJ, Kematick BS, Schmidt M, Wetshtein AM, Scullion B, Herndon CM, Atayee RS. Development of entrustable professional activities for specialist hospice and palliative care pharmacists. Journal of Pain and Symptom Management. 2022 Jul;64(1):37-48., doi: https://doi.org/10.1016/j.jpainsymman.2022.03.004.
Cook H, Walker KA, Lowry MF. Deprescribing interventions by palliative care clinical pharmacists surrounding goals of care discussions. Journal of Palliative Medicine 2022 Jun 14. doi: 10.1089/jpm.2021.0560. Online ahead of print. PMID: 35704875

Presentations
Is dopamine the golden ticket for symptom management in palliative care? Role of antipsychotics for off-label uses [Seminar] The Annual Assembly Hospice and Palliative Care. Virtual Assembly. February 2021.

Pain Management Strategies for Patients with Substance Use Disorder. [Invited Speaker, Continuing Education]. Pitt Pharmacy Spring 2021 Preceptor Continuing Education Seminar. June 1, 2021.

Truth be told or still not sold? The case for Benzodiazepines in the Palliative Management of Delirium [Seminar]. The Annual Assembly Hospice and Palliative Care. Virtual Assembly. February 2022.

Palliative care pharmacist Interventions surrounding Medication Prescribing Across Care Transitions (IMPACT) [Roundtable]. State of the Science in Hospice and Palliative Care. Virtual Conference. February 2022.

Agitation in Dementia: BPSD? Delirium? Pain? A panel discussion. [Invited Speaker]. UPMC Palliative and Supportive Institute. Palliative Care Grand Rounds April 27, 2022.